EUVIMEDEUVIMED entdecken
Open Access

MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis

Jin Tao, Jinshan Cui, Yu Xu, Yafeng Fan, Guodong Hong, Qiaoxia Zhou, Guoqiang Wang, Leo Li, Yusheng Han, Chunwei Xu, Wenxian Wang, Shangli Cai und 1 weitere

Aging · 2024

DOI: 10.18632/aging.205470 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Jin Tao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansMaleImmunotherapyMTOR InhibitorsPhosphatidylinositol 3-KinasesPrognosisTumor MicroenvironmentDNA-Binding ProteinsTranscription Factors

Stichwörter der Autor:innen

MAELclear cell renal cell carcinomaimmunotherapypan-cancer analysisprognosis

Substanzen

MTOR InhibitorsPhosphatidylinositol 3-KinasesMAEL protein, humanDNA-Binding ProteinsTranscription Factors

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Burning Rock Biotech, Guangzhou, Guangdong, China.
  • Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
  • Department of Clinical Trial, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.

Zitieren

APA

Tao, J., Cui, J., Xu, Y., Fan, Y., Hong, G., Zhou, Q., Wang, G., Li, L., Han, Y., Xu, C., Wang, W., Cai, S., & Zhang, X. (2024). MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis. Aging. https://doi.org/10.18632/aging.205470

Vancouver

Tao J, Cui J, Xu Y, Fan Y, Hong G, Zhou Q, et al. MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis. Aging. 2024. doi:10.18632/aging.205470

BibTeX
@article{Tao2024,
  author = {Tao, Jin and Cui, Jinshan and Xu, Yu and Fan, Yafeng and Hong, Guodong and Zhou, Qiaoxia and Wang, Guoqiang and Li, Leo and Han, Yusheng and Xu, Chunwei and Wang, Wenxian and Cai, Shangli and Zhang, Xuepei},
  title = {MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205470}
}
Kostenlos starten →